Published online Sep 16, 2016. doi: 10.4253/wjge.v8.i17.584
Peer-review started: March 25, 2016
First decision: May 17, 2016
Revised: June 8, 2016
Accepted: July 20, 2016
Article in press: July 22, 2016
Published online: September 16, 2016
Processing time: 171 Days and 0.6 Hours
As the number of diagnostic and therapeutic gastrointestinal endoscopies is increasing, and there is an increase in number of patients taking blood thinners, we are seeing more and more patients on blood thinners prior to endoscopic procedures. Gastrointestinal bleeding or thromboembolism can occur in this category of patients in the periendoscopic period. To better manage these patients, endoscopists should have a clear concept about the various blood thinners in the market. Patients’ risk of thromboembolism off anticoagulation, and the risk of bleeding from endoscopic procedures should be assessed prior to endoscopy. The endoscopic procedure should be done when it is safe to do it.
Core tip: While patients on blood thinners undergoing endoscopic procedures are encountered in our clinical practice frequently, endoscopists need to be familiar with the various blood thinners and have a strategy to manage these patients efficiently. This article will discuss the various blood thinners including their mechanism and duration of action, and the current guidelines of performing gastrointestinal endoscopies when the patients are on those blood thinners.